Digestive Diseases and Sciences

, Volume 54, Issue 10, pp 2056–2062 | Cite as

Stat3 Is Involved in Angiotensin II-Induced Expression of MMP2 in Gastric Cancer Cells

  • Wei Huang
  • Li-Fen Yu
  • Jie Zhong
  • Wei Wu
  • Jia-Ying Zhu
  • Feng-Xiang Jiang
  • Yun-Lin Wu
Original Article
First Online:
Received:
Accepted:

Abstract

The expression of matrix metalloproteinase-2 (MMP2) has been linked with tumor invasion, angiogenesis, and metastasis. It has been reported that angiotensin II (Ang II) can induce MMP2 expression in gastric cancer cells. However, the molecular basis for Ang II regulates MMP2 expression in gastric cancer cells remains unclear. The aim of our study is to explore whether angiotensin II could induce MMP2 expression mediated through the Stat signaling pathway and its potential mechanism. Electrophoretic mobility shift assay (EMSA) and chromatin immunoprecipitation (ChIP)-binding assays was employed to determine the DNA-STAT binding activity. MMP2 and VEGF expression was analyzed with real-time PCR and Western blots. To examine the role of Stat3 in angiotensin II-induced MMP2 expression, A JAK-specific inhibitor and AG490 were used. Angiotensin II activated STAT-DNA binding activity in dose–dependent manners in gastric cancer cells. AG490 markedly inhibited angiotensin II-induced Stat3 activation and the expression of MMP2 and VEGF in gastric cancer cells. These results indicate that Stat3 may at least in part mediate angiotensin II-induced MMP2 mRNA expression in human gastric cancer cells. The activation of the JAK/Stat3 signaling pathway plays an important role in the progression of gastric cancer and that blockade of JAK/Stat3 signals may provide a novel therapeutic strategy for gastric cancer.

Keywords

Gastric cancer Angiotensin II Stat3 MMP2 
This is a preview of subscription content, log in to check access.

References

  1. 1.
    Tahara E. Molecular aspects of invasion and metastasis of stomach cancer. Verh Dtsch Ges Pathol. 2000;84:43–49.PubMedGoogle Scholar
  2. 2.
    Guszczyn T, Sobolewski K. Deregulation of collagen metabolism in human stomach cancer. Pathobiology. 2004;71(6):308–313. doi: 10.1159/000081726.PubMedCrossRefGoogle Scholar
  3. 3.
    Deryugina EI, Quigley JP. Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev. 2006;25(1):9–34. doi: 10.1007/s10555-006-7886-9.PubMedCrossRefGoogle Scholar
  4. 4.
    Cai H, Kong ZR, Chen HM. Matrix metalloproteinase-2 and angiogenesis in gastric cancer. Ai Zheng. 2002;21(1):25–28.PubMedGoogle Scholar
  5. 5.
    Shim KN, Jung SA, Joo YH, Yoo K. Clinical significance of tissue levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in gastric cancer. J Gastroenterol. 2007;42(2):120–128. doi: 10.1007/s00535-006-1975-y.PubMedCrossRefGoogle Scholar
  6. 6.
    Escobar E, Rodriguez-Reyna TS, Arrieta O, et al. Angiotensin II, cell proliferation and angiogenesis regulator: biologic and therapeutic implications in cancer. Curr Vasc Pharmacol. 2004;2(4):385–399. doi: 10.2174/1570161043385556.PubMedCrossRefGoogle Scholar
  7. 7.
    Ino K, Shibata K, Kajiyama H, et al. Angiotensin II type 1 receptor expression in ovarian cancer and its correlation with tumour angiogenesis and patient survival. Br J Cancer. 2006;94(4):552–560. doi: 10.1038/sj.bjc.6602961.PubMedCrossRefGoogle Scholar
  8. 8.
    Kikkawa F, Mizuno M, Shibata K, et al. Activation of invasiveness of cervical carcinoma cells by angiotensin II. Am J Obstet Gynecol. 2004;190(5):1258–1263. doi: 10.1016/j.ajog.2003.12.013.PubMedCrossRefGoogle Scholar
  9. 9.
    Huang W, Yu LF, Zhong J, et al. Angiotensin II Type 1 receptor expression in human gastric cancer and induces MMP2 and MMP9 expression in MKN-28 cells. Dig Dis Sci 2007; May 8Google Scholar
  10. 10.
    Seki Y, Kai H, Shibata R, et al. Role of the JAK/STAT pathway in rat carotid artery remodeling after vascular injury. Circ Res. 2000;87(1):12–18.PubMedGoogle Scholar
  11. 11.
    Wang TL, Yang YH, Chang H, et al. Angiotensin II signals mechanical stretch-induced cardiac matrix metalloproteinase expression via JAK-STAT pathway. J Mol Cell Cardiol. 2004;37(3):785–794. doi: 10.1016/j.yjmcc.2004.06.016.PubMedCrossRefGoogle Scholar
  12. 12.
    Xie TX, Wei D, Liu M, et al. Stat3 activation regulates the expression of matrix metalloproteinase-2 and tumor invasion and metastasis. Oncogene. 2004;23:3550–3560. doi: 10.1038/sj.onc.1207383.PubMedCrossRefGoogle Scholar
  13. 13.
    Deshayes F, Nahmias C. Angiotensin receptors: a new role in cancer? Trends Endocrinol Metab. 2005;16(7):293–299. doi: 10.1016/j.tem.2005.07.009.PubMedCrossRefGoogle Scholar
  14. 14.
    Ino K, Shibata K, Kajiyama H, et al. Manipulating the angiotensin system—new approaches to the treatment of solid tumours. Expert Opin Biol Ther. 2006;6(3):243–255. doi: 10.1517/14712598.6.3.243.PubMedCrossRefGoogle Scholar
  15. 15.
    Zheng H, Takahashi H, Murai Y, et al. Expressions of MMP-2, MMP-9 and VEGF are closely linked to growth, invasion, metastasis and angiogenesis of gastric carcinoma. Anticancer Res. 2006;26(5A):3579–3583.PubMedGoogle Scholar
  16. 16.
    Wu ZY, Li JH, Zhan WH, et al. Lymph node micrometastasis and its correlation with MMP-2 expression in gastric carcinoma. World J Gastroenterol. 2006;12(18):2941–2944.PubMedGoogle Scholar
  17. 17.
    Kubben FJ, Sier CF, van Duijn W, et al. Matrix metalloproteinase-2 is a consistent prognostic factor in gastric cancer. Br J Cancer. 2006;94(7):1035–1040. doi: 10.1038/sj.bjc.6603041.PubMedCrossRefGoogle Scholar
  18. 18.
    Bowman T, Garcia R, Turkson J, et al. STATs in oncogenesis. Oncogene. 2000;19:2474–2488. doi: 10.1038/sj.onc.1203527.PubMedCrossRefGoogle Scholar
  19. 19.
    Xie TX, Huang FJ, Aldape KD, et al. Activation of Stat3 in human melanoma promotes brain metastasis. Cancer Res. 2006;66(6):3188–3196. doi: 10.1158/0008-5472.CAN-05-2674.PubMedCrossRefGoogle Scholar
  20. 20.
    Yu LF, Zhu YB, Qiao MM, et al. Constitutive activation and clinical significance of Stat3 in human gastric cancer tissues and cell lines. Zhonghua Yi Xue Za Zhi. 2004;84(24):2064–2069.PubMedGoogle Scholar
  21. 21.
    Kanda N, Seno H, Konda Y, et al. STAT3 is constitutively activated and supports cell survival in association with survivin expression in gastric cancer cells. Oncogene. 2004;23(28):4921–4929. doi: 10.1038/sj.onc.1207606.PubMedCrossRefGoogle Scholar
  22. 22.
    Judd LM, Bredin K, Kalantzis A, et al. STAT3 activation regulates growth, inflammation, and vascularization in a mouse model of gastric tumorigenesis. Gastroenterology. 2006;131(4):1073–1085. doi: 10.1053/j.gastro.2006.07.018.PubMedCrossRefGoogle Scholar
  23. 23.
    Niu G, Wright KL, Huang M, et al. Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis. Oncogene. 2002;21:2000–2008. doi: 10.1038/sj.onc.1205260.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Wei Huang
    • 1
  • Li-Fen Yu
    • 1
  • Jie Zhong
    • 1
  • Wei Wu
    • 1
  • Jia-Ying Zhu
    • 2
  • Feng-Xiang Jiang
    • 1
  • Yun-Lin Wu
    • 1
  1. 1.Department of GastroenterologyRuijin Hospital, Jiaotong University School of MedicineShanghaiChina
  2. 2.Department of EmergencyGuizhou Provincial People’s HospitalGuiyangChina

Personalised recommendations